19
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Disappearance of Heme Metabolites Following Chelation Therapy with Meso 2,3 - Dimercaptosuccinic Acid (DMSA)

&
Pages 267-276 | Published online: 25 Sep 2008

References

  • Rutter M, Jones R S. Lead Versus Health. John Wiley and Sons, New York 1983; 72
  • World Health Organization. Recommended Health Based Limits in Occupational Exposure to Heavy Metals. Technical Report Series 647, WHO, Geneva 1980; 34
  • Goering P L. Lead-protein interactions as a basis for lead toxicity. Neurotoxicology 1993; 14: 45–60
  • Lee W R. What happens in lead poisoning. J R Coll Phys Lond 1981; 15: 48–54
  • Meredith P A, Moore R M. An evaluation of the use of haem-biosynthetic parameters in the detection of industrial and environmental lead exposure. Biochem Soc Trans 1979; 7: 39–41
  • Somashekaraiah B V, Venkaiah B, Prasad A R. Biochemical diagnosis of occupational exposure to lead toxicity. Bull Environ Contam Toxicol 1990; 44: 268–275
  • Bulman R A. The chemistry of chelating agents in medical sciences. National Radiological Protection Board, Chilton, DidcotEngland 1987; 109–132
  • Welcher F J. The Analytical Uses of EDTA. D Van Nostrand, NJ, Princeton, NJ 1957
  • Chisolm J J. The use of chemistry agents in the treatment of acute and chronic lead intoxication in children. J Pediatr 1987; 73: 1–10
  • Graziano J H, Lolacono N J, Moulton T, et al. Controlled study of meso 2,3- dimercaptosuccinic acid for the management of childhood lead intoxication. J Pediatr 1992; 120: 133–139
  • A New Look at Lead Toxicity. Conference on Childhood Lead Toxicity, Comtact Corporation. June, 1990

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.